NovaBay Pharmaceuticals CFO Jason Raleigh receives $334K in 2019

NovaBay Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: April 15, 2020

NovaBay Pharmaceuticals reported fiscal year 2019 executive compensation information on April 15, 2020.
In 2019, four executives at NovaBay Pharmaceuticals received on average a compensation package of $225K, a 51% decrease compared to previous year.
Average pay of disclosed executives at NovaBay Pharmaceuticals
Jason Raleigh, Chief Financial Officer, received $334K in total. 67% of Raleigh's compensation, or $225K, was in salary. Raleigh also received $109K in bonus and $480 in other compensation.
Justin M. Hall, Chief Executive Officer, received a compensation package of $326K, which decreased by 43% compared to previous year. 80% of the compensation package, or $260K, was in salary.
Wang Xu, Senior M and Controller, earned $168K in 2019.
John J. McGovern, Chief Executive Officer, received $70K in 2019, which decreases by 91% compared to 2018.

Related executives

Justin Hall

NovaBay Pharmaceuticals

Chief Executive Officer

Wang Xu

NovaBay Pharmaceuticals

Senior Manager and Controller

Jason Raleigh

NovaBay Pharmaceuticals

Chief Financial Officer

John McGovern

NovaBay Pharmaceuticals

Chief Executive Officer

You may also like

Source: SEC filing on April 15, 2020.